Lila Sciences, a Cambridge-based AI-biotech startup, raised $235 million to achieve unicorn status at over $1 billion valuation, following a $200 million seed round. It develops a “scientific superintelligence” platform integrating AI and robotic labs for accelerated drug discovery and sustainable materials. This funding reflects booming investor interest in AI-driven life sciences innovation.

Will the company falter in its expansion plans amid intensifying competition from rivals like Snowflake?

Trump’s White House is all-in on building powerful American artificial intelligence. The populist base is starting to push back.

“This technology is able to detect abnormalities in the grid and help us understand when we’re having a cyber attack or disturbance so we can quickly respond and mitigate it,”

The state’s landmark safety bill sets new transparency requirements for large AI companies.

California finalizes 2025 CCPA rules, imposing audits, risk checks, and AI oversight—reshaping how businesses handle sensitive data.

For the third year, the state delayed AI regulation for disclosing and appealing many automated decisions by the state and companies

As Apple lags behind, it’s losing top AI-focused employees.

Uttar Pradesh has laid out its ‘Vixit UP at 2047’ vision, an ambitious plan to establish the state as a global technology player and grow its economy to $6 t…